[1] |
Monastero R, Cicero CE, Baschi R, et al. Mild cognitive impairment in Parkinson’s disease: the Parkinson’s disease cognitive study (PACOS)[J]. J Neurol, 2018, 265(5): 1050-1058.
|
[2] |
Aarsland D, Andersen K, Larsen JP, et al. Prevalence and characteristics of dementia in Parkinson disease: an 8-year Prospective study[J]. Arch Neurol, 2003, 60(3): 387-392.
|
[3] |
Reid WG, Hely MA, Morris JG, et al. A longitudinal of Parkinson’s disease: clinical and neuropsychological correlates of dementia[J]. J Clin Neurosci, 1996, 3(4): 327-333.
|
[4] |
Fernandez HH, Lapane KL. Predictors of mortality among nursing home residents with a diagnosis of Parkinson’s disease[J]. Med Sci Monit, 2002, 8(4): Cr241-Cr246.
|
[5] |
Bäckström D, Granösen G, Domellöf ME, et al. Early predictors of mortality in Parkinsonism and Parkinson disease: a population-based study[J]. Neurology, 2018, 91(22): e2045-e2056.
|
[6] |
Postuma RB, Berg D, Stern M, et al. MDS clinical diagnostic criteria for Parkinson’s disease[J]. Mov Disord, 2015, 30(12): 1591-1601.
|
[7] |
Litvan I, Goldman JG, Troster AI, et al. Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: movement disorder society task force guidelines[J]. Mov Disord, 2012, 27(3): 349-356.
|
[8] |
Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician[J]. J Psychiatr Res, 1975, 12(3): 189-198.
|
[9] |
Hoops S, Nazem S, Siderowf AD, et al. Validity of the moca and mmse in the detection of mci and dementia in Parkinson disease[J]. Neurology, 2009, 73(21): 1738-1745.
|
[10] |
Dalrymple-Alford JC, MacAskill MR, Nakas CT, et al. The MoCA: well-suited screen for cognitive impairment in Parkinson disease[J]. Neurology, 2010, 75(19): 1717-1725.
|
[11] |
Brown DS, Bernstein IH, McClintock SM, et al. Use of the montreal cognitive assessment and Alzheimer’s disease-8 as cognitive screening measures in Parkinson’s disease[J]. Int J Geriatr Psychiatry, 2016, 31(3): 264-272.
|
[12] |
Ozer S, Young J, Champ C, et al. A systematic review of the diagnostic test accuracy of brief cognitive tests to detect amnestic mild cognitive impairment[J]. Int J Geriatr Psychiatry, 2016, 31(11): 1139-1150.
|
[13] |
Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality[J]. Neurology, 1967, 17(5): 427-442.
|
[14] |
Wu L, Liu FT, Ge JJ, et al. Clinical characteristics of cognitive impairment in patients with Parkinson’s disease and its related pattern in 18F-FDG pet imaging[J]. Hum Brain Mapp, 2018, 39(12): 4652-4662.
|
[15] |
Nie K, Gao Y, Mei M, et al. The clinical characteristics and cognitive features of mild cognitive impairment in Parkinson’s disease and the analysis of relevant factors[J]. J Clin Neurosci, 2019, 63: 142-148.
|
[16] |
Cholerton B, Johnson CO, Fish B, et al. Sex differences in progression to mild cognitive impairment and dementia in Parkinson’s disease[J]. Parkinsonism Relat Disord, 2018, 50: 29-36.
|
[17] |
Buter TC, van den Hout A, Matthews FE, et al. Dementia and survival in Parkinson disease: a 12-year population study[J]. Neurology, 2008, 70(13): 1017-1022.
|
[18] |
Galtier I, Nieto A, Lorenzo JN, et al. Mild cognitive impairment in Parkinson’s disease: diagnosis and progression to dementia[J]. J Clin Exp Neuropsychol, 2016, 38(1): 40-50.
|
[19] |
Lichter DG, Benedict RHB, Hershey LA. Importance of balance-gait disorder as a risk factor for cognitive impairment, dementia and related non-motor symptoms in Parkinson’s disease[J]. J Parkinsons Dis, 2018, 8(4): 539-552.
|
[20] |
Muslimovic D, Post B, Speelman JD, et al. Determinants of disability and quality of life in mild to moderate Parkinson disease[J]. Neurology, 2008, 70(23): 2241-2247.
|
[21] |
Mirza SS, Ikram MA, Bos D, et al. Mild cognitive impairment and risk of depression and anxiety: a population-based study[J]. Alzheimers Dement, 2017, 13(2): 130-139.
|
[22] |
Schrag A, Siddiqui UF, Anastasiou Z, et al. Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson’s disease: a cohort study[J]. Lancet Neurol, 2017, 16(1): 66-75.
|